基于结构-行为-绩效分析范式的药品流通领域供给侧结构性改革策略分析

发布时间：2018-03-18 03:22

本文选题：结构-行为-绩效分析　切入点：药品流通　出处：《中国药房》2017年10期 　论文类型：期刊论文

【摘要】：目的:为我国药品流通行业开展供给侧结构性改革提供产业组织研究基础和发展建议。方法:运用哈佛学派的结构-行为-绩效(SCP)分析范式对2010年以来我国药品流通行业的市场结构、企业行为、经营绩效进行深入研究。结果:自2010年以来,我国药品流通行业呈规模增速下降、市场集中度降低、行业进入壁垒提高、国有资本主导等态势。尽管企业兼并重组和上市融资规模扩大,管理信息化、第三方物流、"互联网+"和药店联盟等经营模式蓬勃发展,但行业经营绩效差,国有企业整体表现不佳。结论:应针对性地加快推进药品流通行业的供给侧结构性改革,鼓励企业融资兼并,破除地方保护主义,发展合作式第三方医药物流和药店联盟,借力互联网推动行业经营模式的转型升级。
[Abstract]:Objective: to provide the research basis and development suggestion of industrial organization for the supply-side structural reform of the pharmaceutical circulation industry in China. Methods: to apply the structure-behavior-performance analysis paradigm of Harvard School to the pharmaceutical industry since 2010 in China. The market structure of the circulation industry, Results: since 2010, the scale of drug circulation industry in China has decreased, the market concentration has decreased, and the barriers to entry have been raised. Although enterprises' merger and reorganization and the scale of listed financing, management information, third party logistics, "Internet" and drugstore alliance have developed vigorously, but the performance of the industry is poor, Conclusion: the supply-side structural reform of pharmaceutical circulation industry should be accelerated, enterprise financing and merger should be encouraged, local protectionism should be eliminated, and cooperative third-party medical logistics and drugstore alliance should be developed. Use the Internet to promote the transformation and upgrading of the business model of the industry.
【作者单位】：中国药科大学国际医药商学院;昆明医科大学药学院暨云南省天然药物药理重点实验室;
【基金】：国家社会科学基金项目(No.14BGL144) 云南省天然药物药理重点实验室开放基金(No.2015G001)
【分类号】：R95

【参考文献】